Literature DB >> 11175812

Blockade of eosinophil migration and airway hyperresponsiveness by cPLA2-inhibition.

S Myou1, H Sano, M Fujimura, X Zhu, K Kurashima, T Kita, S Nakao, A Nonomura, T Shioya, K P Kim, N M Munoz, W Cho, A R Leff.   

Abstract

We examined the role of a cytosolic phospholipase A2 (cPLA2) in antigen-induced eosinophil infiltration of airways and in airway hyperresponsiveness to methacholine. Inhibition of cPLA2, or blockade of the platelet-activating factor (PAF) receptor, blocked antigen-induced airway hyperresponsiveness and suppressed eosinophil infiltration. Neither cyclooxygenase nor 5-lipoxygenase inhibition had either effect. We show here that, in antigen-sensitized guinea pigs, cPLA2 inhibition prevents both eosinophilic infiltration and subsequent airway hyperresponsiveness after antigen challenge. We also show that this effect is mediated by first-step hydrolysis of membrane phospholipid into lysophospholipid rather than by prostanoid or leukotriene metabolites of arachidonate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175812     DOI: 10.1038/84244

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  20 in total

Review 1.  Multiple roles of phospholipase A2 during lung infection and inflammation.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

Review 2.  What targeting eosinophils has taught us about their role in diseases.

Authors:  Bruce S Bochner; Gerald J Gleich
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

3.  The RNA-binding protein HuR stabilizes cytosolic phospholipase A2α mRNA under interleukin-1β treatment in non-small cell lung cancer A549 Cells.

Authors:  Wan-Lin Liao; Wei-Chiao Wang; Wen-Chang Chang; Joseph T Tseng
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

4.  Mechanism of glutamine inhibition of cytosolic phospholipase a2 (cPLA2 ): Evidence of physical interaction between glutamine-Induced mitogen-activated protein kinase phosphatase-1 and cPLA2.

Authors:  C-H Lee; H-K Kim; J-S Jeong; Y-D Lee; Z Wu Jin; S-Y Im; H-K Lee
Journal:  Clin Exp Immunol       Date:  2015-04-29       Impact factor: 4.330

5.  Cytosolic phospholipase A(2) in hypoxic pulmonary vasoconstriction.

Authors:  Fumito Ichinose; Roman Ullrich; Adam Sapirstein; Rosemary C Jones; Joseph V Bonventre; Charles N Serhan; Kenneth D Bloch; Warren M Zapol
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

6.  The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors.

Authors:  Shawn G Payne; Carole A Oskeritzian; Rachael Griffiths; Preeti Subramanian; Suzanne E Barbour; Charles E Chalfant; Sheldon Milstien; Sarah Spiegel
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

Review 7.  The role of sphingosine-1-phosphate and its receptors in asthma.

Authors:  John J Ryan; Sarah Spiegel
Journal:  Drug News Perspect       Date:  2008-03

8.  Regulation of adhesion of AML14.3D10 cells by surface clustering of beta2-integrin caused by ERK-independent activation of cPLA2.

Authors:  Shigeharu Myou; Xiangdong Zhu; Evan Boetticher; Yimin Qin; Saori Myo; Angelo Meliton; Anissa Lambertino; Nilda M Munoz; Kimm J Hamann; Alan R Leff
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

9.  Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation.

Authors:  Ines Lindner; Christiane Meier; Angelika Url; Hermann Unger; Andreas Grassauer; Eva Prieschl-Grassauer; Petra Doerfler
Journal:  BMC Immunol       Date:  2010-05-21       Impact factor: 3.615

10.  Chemotaxis of bone marrow derived eosinophils in vivo: a novel method to explore receptor-dependent trafficking in the mouse.

Authors:  Eva M Sturm; Kimberly D Dyer; Caroline M Percopo; Akos Heinemann; Helene F Rosenberg
Journal:  Eur J Immunol       Date:  2013-06-14       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.